Omnipod Insulin System approved for T1D; More than 37 million Americans with diabetes; Goodbye, BPA?

The FDA has cleared the Omnipod automated insulin delivery system — the first tubeless device of its kind with smartphone control — for people as young as 6 years old with type 1 diabetes, Insulet announced.

A total of 37.3 million Americans have diabetes, representing 11.3% of the US population, according to new data from the CDC. Among this population, 28.7 million people have been correctly diagnosed while the remaining 8.5 million are undiagnosed.

In Ontario, aspirin was given to only 38.8% of pregnant women with diabetes, obesity and hypertension before pregnancy to prevent preeclampsia. (JAMA)

Along with a slew of doctors, scientists, and public health and environmental organizations, the Endocrine Society said it added its name to an official petition sent to the FDA to rescind bisphenol A (BPA) approvals. in adhesives and coatings and set strict limits on its use in food-grade plastics.

The Endocrine Society also announced the launch of its renewed patient outreach program, featuring new in-person health education events as well as a new consumer health education web presence.

In the second publicity error since December, Eli Lilly was again reprimanded by the FDA, this time for an Instagram post about Trulicity (dulaglutide) that failed to list all of the safety issues. (FiercePharma)

In a study of more than one million people with chronic conditions, such as diabetes, those who also had psychiatric comorbidities had a significantly higher risk of death from all causes. (PLoS medicine)

Mental health start-up Cerebral has had its adverts pulled from several social media platforms, including TikTok and Instagram, after running an ad referring to obesity “five times more common” in people with ADHD. (USA today)

  • Kristen Monaco is a writer, specializing in endocrinology, psychiatry and nephrology news. Based in the New York office, she has been with the company since 2015.

Comments are closed.